Xu Xiaowei, Zheng Jie, Zou Qianqian, Wang Chao, Zhang Xinjie, Wang Xuetao, Liu Yang, Shu Jianbo
Tianjin Pediatric Research Institute, Tianjin Children's Hospital, Tianjin 300134, P.R. China.
Tianjin Key Laboratory of Prevention and Treatment of Birth Defects, Tianjin Children's Hospital, Tianjin 300134, P.R. China.
Exp Ther Med. 2021 Apr;21(4):403. doi: 10.3892/etm.2021.9834. Epub 2021 Feb 25.
The present study aimed to analyze gene mutations in patients with β-ureidopropinoase deficiency and establish a rapid detection method for β-ureidopropinoase () pathogenic variations by high resolution melting (HRM) analysis. DNA samples with known mutations in three patients with β-ureidopropinoase deficiency were utilized to establish a rapid detection method for pathogenic variations by HRM analysis. Further rapid screening was performed on two patients diagnosed with β-ureidopropinoase deficiency and 50 healthy control individuals. The results showed that all known gene mutations can be analyzed by a specially designed HRM assay. Each mutation has specific HRM profiles which could be used in rapid screening. The HRM method could correctly identify all genetic mutations in two children with β-ureidopropinoase deficiency. In addition, the HRM assay also recognized four unknown mutations. To conclude, the results support future studies of applying HRM analysis as a diagnostic approach for β-ureidopropinoase deficiency and a rapid screening method for mutation carriers.
本研究旨在分析β-脲基丙酸酶缺乏症患者的基因突变,并通过高分辨率熔解(HRM)分析建立一种快速检测β-脲基丙酸酶()致病变异的方法。利用3例β-脲基丙酸酶缺乏症患者已知突变的DNA样本,通过HRM分析建立一种快速检测致病变异的方法。对2例诊断为β-脲基丙酸酶缺乏症的患者和50名健康对照个体进行了进一步的快速筛查。结果表明,所有已知的基因突变都可以通过专门设计的HRM检测进行分析。每个突变都有特定的HRM图谱,可用于快速筛查。HRM方法能够正确识别2例β-脲基丙酸酶缺乏症患儿的所有基因突变。此外,HRM检测还识别出4个未知突变。总之,这些结果支持未来将HRM分析作为β-脲基丙酸酶缺乏症的诊断方法和致病突变携带者的快速筛查方法的研究。